QIAGEN N.V. (QGEN) recently entered into a cooperative research and development agreement (CRADA) with the Federal Bureau of Investigation (FBI). The deal advances a novel test for its QIAcuity digital PCR devices that will enhance forensics by improving the quantification of DNA in human samples. The recent development will strengthen QIAGEN’s leading position in the human identification (HID) and forensics business. More on the News As a federally accredited laboratory, the FBI performs research and devel ...